toggle mobile menu Menu
toggle search menu

Site Navigation



Eric M. Fountain, MD

Eric M. Fountain, MD


Doctor of Medicine

St. Luke's Health Partner
St. Luke's Health Partner

These providers work together to achieve patient-centered care, using proven best practices to offer better care to you and your family.


Accepting new patients
No Referral Required

Facilities & Clinics

About Eric M. Fountain


Eric Fountain MD, MA is a hematologist and oncologist with interests that include lymphoma, prostate cancer, kidney cancer, lung cancer, and gastrointestinal cancers.

Dr. Fountain taught high school science and mathematics before beginning his career in medicine, and his experiences as a teacher as well as his own family’s struggles with cancer shaped his personalized approach to cancer care. For both benign and malignant conditions, his management is tailored to the biology of disease, latest treatments, and most importantly, a patient’s unique personal circumstances to promote physical and mental well-being. 

Dr. Fountain’s scholarly works on platelet disorders and immunotherapy in rare disorders have been published in numerous journals. At MD Anderson Cancer Center, he led a multidisciplinary team to improve outcomes in patients who receive mechanical filters to prevent blood clots.

Dr. Fountain lives in Boise with his wife, a St. Luke’s OB/GYN, and their children. 

  • Medical School

    University of Colorado Anschutz Medical Campus
  • Residency

    Duke University School of Medicine
  • Fellowship

    MD Anderson Cancer Center
  • Board Certifications

    Internal Medicine
    Medical Oncology
  • Gender

  • Languages Spoken



Manasanch EE, Berrios D, Fountain E, et al. Gene expression profiling predicts relapse-free and overall survival in newly diagnosed myeloma patients treated with novel therapies. Br J Haematol. 2021. 

Davila-Gonzalez D, Barrios-Ruiz A, Fountain E, et al. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center. Clin Lymphoma Myeloma Leuk. 2020. Nov 5; S2152-2650.  

Fountain E, Bassett RL, Cain S, Posada L, Gombos DS, Hwu P, Bedikian A, Patel SP. Adjuvant Ipilimumab in High-Risk Uveal Melanoma. (Accepted for Publication – Cancers, 12/2018)

Fountain E, Mistry H, Jain P, Duvic M, Fowler N. Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides. Leuk Lymphoma. 2018 Oct 10:1-4

Fountain EM, Arepally GM. Etiology and complications of thrombocytopenia in hospitalized medical patients. J Thromb Thrombolysis. 2017 May;43(4):429-436.

Fountain EM, Moses MC, Park LP, Woods CW, Arepally GM. Thrombocytopenia in hospitalized medical patients with severe clostridium difficile infection. J Thromb Thrombolysis. 2017 Jan;43(1):38-42.

Abril MK, Barnett AS, Wegermann K, Fountain E, Strand A, Heyman BM, et al. Diagnosis of Capnocytophaga canimorsus sepsis by whole-genome next-generation sequencing. Open Forum Infect Dis. 2016 Jul 12;3(3):ofw144.

Fountain EM, Dhurandhar A. Neuro-Behcet’s Disease: An Unusual Cause of Headache. J Gen Intern Med. 2014 Jun 29;6:956-60.

Bakajin O., Fountain E, Morton K, et al. Materials Aspects in Micro- and Nanofluidic Systems Applied to Biology. MRS Bulletin 31, Special Issue on Materials for Micro and Nanofluidics. 2006. 108-113.

Learn More about Dr. Fountain